# OnCo record opamtistomig (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/opamtistomig/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "opamtistomig" ;
  schema:name "Opamtistomig"@en ;
  schema:alternateName "LBL-024"@en ;
  schema:description "Opamtistomig is an experimental bispecific antibody from Nanjing Leads Biolabs, in phase 3 trials for extrapulmonary neuroendocrine carcinoma, small cell lung cancer and non-small cell lung cancer and other cancers."@en ;
  schema:url <https://onco.cc/drugs/opamtistomig/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.leadsbiolabs.com/_nuxt/C0xAGIJr.js>, <https://www.leadsbiolabs.com/_nuxt/C0xAGIJr.js>, <https://www.biospace.com/press-releases/priority-review-granted-to-pd-l1-4-1bb-bispecific-antibody-opamtistomig-accelerating-commercialization-and-addressing-unmet-need-in-ep-nec>, <https://biospectrumasia.com/news/99/28249/leads-biolabs-opamtistomig-nda-accepted-in-china-for-neuroendocrine-carcinoma.html>, <https://clinicaltrials.gov/search?intr=LBL-024> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Bispecific antibody (2:2 format)" ;
  onco:cancers <https://onco.cc/cancers/extrapulmonary-nec/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/oesophageal-squamous-cell-carcinoma/>, <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/platinum-resistant-ovarian-cancer/>, <https://onco.cc/cancers/colorectal/> ;
  onco:targets <https://onco.cc/targets/pdl1/>, <https://onco.cc/targets/cd137/> ;
  onco:companies <https://onco.cc/companies/nanjing-leads-biolabs/> ;
  onco:trials <https://onco.cc/trials/nct05170958/>, <https://onco.cc/trials/nct06157827/>, <https://onco.cc/trials/nct06783647/>, <https://onco.cc/trials/nct07042802/>, <https://onco.cc/trials/nct07099430/>, <https://onco.cc/trials/nct07111546/>, <https://onco.cc/trials/nct07281976/>, <https://onco.cc/trials/nct07331155/>, <https://onco.cc/trials/nct07390383/>, <https://onco.cc/trials/nct07720193/>, <https://onco.cc/trials/nct07791758/> .